Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126573641 | 12657364 | 1 | I | 20160718 | 20160726 | 20160816 | 20160816 | PER | US-ASTRAZENECA-2016SE81662 | ASTRAZENECA | 20223.00 | DY | M | Y | 98.90000 | KG | 20160816 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126573641 | 12657364 | 1 | PS | LIDOCAINE. | LIDOCAINE | 1 | Unknown | U | 6488 | ||||||||||
| 126573641 | 12657364 | 2 | SS | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Oral | 6100 | MG | U | 0 | 100 | MG | MODIFIED-RELEASE TABLET | QD | ||||
| 126573641 | 12657364 | 3 | SS | PRILOSEC OTC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 1220 | MG | U | 0 | 20 | MG | MODIFIED-RELEASE TABLET | BID | ||||
| 126573641 | 12657364 | 4 | SS | PRILOSEC OTC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 1220 | MG | U | 0 | 20 | MG | MODIFIED-RELEASE TABLET | BID | ||||
| 126573641 | 12657364 | 5 | SS | BRILINTA | TICAGRELOR | 1 | Oral | 10980 | MG | U | 0 | 90 | MG | TABLET | BID | ||||
| 126573641 | 12657364 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 126573641 | 12657364 | 7 | C | PEPCID AC | FAMOTIDINE | 1 | 0 | 20 | MG | BID | |||||||||
| 126573641 | 12657364 | 8 | C | CARAFATE LIQUID | 2 | 0 | 10 | ML | QID | ||||||||||
| 126573641 | 12657364 | 9 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 0 | 40 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126573641 | 12657364 | 2 | Blood pressure abnormal |
| 126573641 | 12657364 | 3 | Gastrooesophageal reflux disease |
| 126573641 | 12657364 | 4 | Gastrooesophageal reflux disease |
| 126573641 | 12657364 | 5 | Stent placement |
| 126573641 | 12657364 | 6 | Cardiac disorder |
| 126573641 | 12657364 | 7 | Gastrooesophageal reflux disease |
| 126573641 | 12657364 | 8 | Gastrooesophageal reflux disease |
| 126573641 | 12657364 | 9 | Gastrooesophageal reflux disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126573641 | 12657364 | Blood pressure increased | |
| 126573641 | 12657364 | Chest pain | |
| 126573641 | 12657364 | Dyspepsia | |
| 126573641 | 12657364 | Palpitations | |
| 126573641 | 12657364 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126573641 | 12657364 | 2 | 201605 | 0 | ||
| 126573641 | 12657364 | 3 | 201606 | 0 | ||
| 126573641 | 12657364 | 4 | 201606 | 0 | ||
| 126573641 | 12657364 | 5 | 201605 | 0 | ||
| 126573641 | 12657364 | 7 | 20160719 | 0 | ||
| 126573641 | 12657364 | 9 | 201607 | 0 |